AGH 4.9 0.00 Vol 0 BAS 1.75 0.00 Vol 0 BFM 22.75 0.75 Vol 10000 BG23B 0 0.00 Vol 0 BPH 4.26 0.00 Vol 0 DEVON 2.25 0.00 Vol 0 LOM 3.2 0.00 Vol 0 NTB 38 0.00 Vol 0 POLAR 0 0.00 Vol 0 SOM 17 0.00 Vol 0 WHHL 4.2 0.00 Vol 0 WWW 29 0.00 Vol 0
Market Closed:
Clarendon House
2 Church Street
Hamilton HM11
Bermuda

www.iterumtx.com
Listed Since: 2021/01/26
Currency: USD

 

Iterum Therapeutics Bermuda Limited., is a Bermuda exempted company limited by shares incorporated on November 6, 2019. They are a direct wholly owned finance subsidiary of the Parent; (Iterum Therapeutics plc, a public limited company formed under the laws of Ireland. Registered office located at Block 2 Floor 3, Harcourt Centre, Harcourt Street, Dublin 2, Ireland) It is intended that the Issuer will be managed and controlled in Ireland on an on-going basis. Issuer’s Registered office is located at Clarendon House, 2 Church Street, Hamilton HM11, Bermuda.

Exchangeable Notes in an aggregate principal amount of $51,588,000 were issued under an indenture, dated as of January 21, 2020, by and among Iterum Therapeutics Bermuda Limited (the “Issuer”), Iterum Therapeutics plc (the “Parent”), Iterum Therapeutics International Limited, Iterum Therapeutics US Limited and Iterum Therapeutics US Holding Limited (the Parent, Iterum Therapeutics International Limited, Iterum Therapeutics US Limited and Iterum Therapeutics US Holding Limited collectively, the “Guarantors”) and U.S. Bank National Association, as trustee, (the “Exchangeable Notes Indenture”) in a private placement (the “Private Placement”) pursuant to a securities purchase agreement by and among the Issuer, the Guarantors and the investors thereto (the “Purchase Agreement”), and additional Exchangeable Notes in an aggregate principal amount of $220,000 were issued to the holders of Parent ordinary shares as of the record date, August 5, 2020, pursuant to a rights offering (the “Rights Offering”), which closed on September 8, 2020.

Iterum Therapeutics Bermuda Limited., US$$51,588,000 - 6.500% Exchangeable Senior Subordinated Notes due January 31, 2025.,

FINANCIAL AND OTHER INFORMATION

DIRECTORY

LISTING SPONSOR

TRADING HOURS

08:30-09:00 Price Discovery
09:00-16:30 Continuous Trading

CONTACT DETAILS

TEL: +1 (441) 292 7212
FAX: +1 (441) 292 7619
Email: info@bsx.com

LOCATION

30 Victoria Street
3rd Floor
Hamilton, Bermuda

MAILING ADDRESS

P.O. Box HM 1369
Hamilton HMFX

Disclaimer

 

The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website.